Get started
Author

Valentina Citro

Observed names: Citro, V., Citro, Valentina, V. Citro
Institution: University of Milan
ORCID: 0000-0002-0289-404X
Observed ORCID: 0000-0002-0289-404X
OpenAlex ID: A5064914964
The molecular function and clinical phenotype of partial deletions of the IGF2/H19 imprinting control region depends on the spatial arrangement of the remaining CTCF-binding sites
2012 · Jasmin Beygo, Valentina Citro, et al. · Human Molecular Genetics · 90
PDF
Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour
2008 · F. Cerrato, A. Sparago, et al. · Human Molecular Genetics · 85
PDF
Nanoplastic impact on bone microenvironment: A snapshot from murine bone cells
2023 · Domenica Giannandrea, Marco Parolini, et al. · Journal of Hazardous Materials · 51
PDF
Inherited and Sporadic Epimutations at the IGF2-H19 Locus in Beckwith-Wiedemann Syndrome and Wilms’ Tumor
2009 · Andrea Riccio, Angela Sparago, et al. · Endocrine development · 50
A splicing mutation of the HMGA2 gene is associated with Silver–Russell syndrome phenotype
2015 · Agostina De Crescenzo, Valentina Citro, et al. · Journal of Human Genetics · 42
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way
2022 · Domenica Giannandrea, Natalia Platonova, et al. · Haematologica · 40
PDF
The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers
2018 · Valentina Citro, Chiara Cimmaruta, et al. · International Journal of Molecular Sciences · 40
PDF
Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests
2011 · Giuseppina Andreotti, Valentina Citro, et al. · Orphanet Journal of Rare Diseases · 36
PDF
Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease
2016 · Valentina Citro, Jorge Peña-García, et al. · PLoS ONE · 32
PDF
Drug repositioning can accelerate discovery of pharmacological chaperones
2015 · Bruno Hay Mele, Valentina Citro, et al. · Orphanet Journal of Rare Diseases · 31
PDF
The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations
2016 · Valentina Citro, Marco Cammisa, et al. · International Journal of Molecular Sciences · 30
PDF
Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2
2015 · Giuseppina Andreotti, Maria Chiara Monti, et al. · PLoS ONE · 30
PDF
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease
2020 · Susanne Seemann, Mathias Ernst, et al. · Biochemical Journal · 24
PDF
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase
2018 · Chiara Cimmaruta, Valentina Citro, et al. · BMC Bioinformatics · 21
PDF
Restoring Tissue Homeostasis at Metastatic Sites: A Focus on Extracellular Vesicles in Bone Metastasis
2021 · Domenica Giannandrea, Valentina Citro, et al. · Frontiers in Oncology · 20
PDF
A thermodynamic assay to test pharmacological chaperones for Fabry disease
2013 · Giuseppina Andreotti, Valentina Citro, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 18
PDF
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG
2017 · Valentina Citro, Chiara Cimmaruta, et al. · PLoS ONE · 15
PDF
D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR
2017 · Gabriele Eden, Marco Archinti, et al. · Cellular and Molecular Life Sciences · 15
Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells
2020 · Maria Teresa Palano, Domenica Giannandrea, et al. · Cancers · 12
PDF
In silico docking of urokinase plasminogen activator and integrins
2008 · Bernard Degryse, Juan Fernandez-Recio, et al. · BMC Bioinformatics · 11
PDF
Sex Steroid Regulation of Oxidative Stress in Bone Cells: An In Vitro Study
2021 · Valeria Sibilia, Daniele Bottai, et al. · International Journal of Environmental Research and Public Health · 7
PDF
E-Learning for Rare Diseases: An Example Using Fabry Disease
2017 · Chiara Cimmaruta, Ludovica Liguori, et al. · International Journal of Molecular Sciences · 6
PDF
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
2017 · Jan Lukas, Anne-Marie Knospe, et al. · Journal of Visualized Experiments · 5
PDF
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma
2023 · Natalia Platonova, Elisa Lazzari, et al. · International Journal of Molecular Sciences · 4
PDF
D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo
2017 · Federico Furlan, Gabriele Eden, et al. · Peptides · 4
Works count: 47
Citation count: 721
H-index: 16
I10-index: 20
Year
Topic
Type